TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies: Strong Buy Rating Backed by HEPLISAV-B Growth and Strategic Initiatives
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Dynavax's Market Dominance and Buoyant Growth Prospects Affirm Buy Rating
Dynavax's Strong Growth and Market Share Expansion Drive Buy Rating
Dynavax Technologies Analyst Ratings
Dynavax Technologies Analyst Ratings
Dynavax Technologies Analyst Ratings
Dynavax Technologies: A Stable Hold Amidst a Catalyst-Deficient Forecast
Dynavax Technologies Analyst Ratings
JMP Securities Maintains Market Outperform on Dynavax Technologies, Raises Price Target to $27
Dynavax Technologies Analyst Ratings